Quênia - inglês - Pharmacy and Poisons Board

laboratory & allied ltd 42875 00100 nairobi kenya - acyclovir - eye ointment - acyclovir 30mg/gram - ophthalmological anti-infectives: antivirals

Arábia Saudita - inglês - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

alcon cusi - aciclovir - eye ointment - 3 %

União Europeia - inglês - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - efavirenz - hiv infections - antivirals for systemic use - sustiva is indicated in antiviral combination treatment of human-immunodeficiency-virus-1 (hiv-1)-infected adults, adolescents and children three years of age and older.sustiva has not been adequately studied in patients with advanced hiv disease, namely in patients with cd4 counts < 50 cells/mm3, or after failure of protease-inhibitor (pi)-containing regimens. although cross-resistance of efavirenz with pis has not been documented, there are at present insufficient data on the efficacy of subsequent use of pi-based combination therapy after failure of regimens containing sustiva.

União Europeia - inglês - EMA (European Medicines Agency)

merck sharp & dohme b.v. - efavirenz - hiv infections - antivirals for systemic use - stocrin is indicated in antiviral combination treatment of human-immunodeficiency-virus-1 (hiv-1)-infected adults, adolescents and children three years of age and older.stocrin has not been adequately studied in patients with advanced hiv disease, namely in patients with cd4 counts < 50 cells/mm3, or after failure of protease-inhibitor (pi)-containing regimens. although cross-resistance of efavirenz with pis has not been documented, there are at present insufficient data on the efficacy of subsequent use of pi-based combination therapy after failure of regimens containing stocrin.

União Europeia - inglês - EMA (European Medicines Agency)

teva b.v. - efavirenz - hiv infections - antivirals for systemic use - efavirenz is indicated in antiviral combination treatment of human-immunodeficiency-virus-1 (hiv-1)-infected adults, adolescents and children 3 years of age and older.efavirenz has not been adequately studied in patients with advanced hiv disease, namely in patients with cd4 counts < 50 cells/mm3, or after failure of protease inhibitor (pi)-containing regimens. although cross-resistance of efavirenz with protease inhibitors (pis) has not been documented, there are at present insufficient data on the efficacy of subsequent use of pi-based combination therapy after failure of regimens containing efavirenz.

Tanzânia - inglês - Tanzania Medicinces & Medical Devices Authority

centaur pharmaceuticals private limited, india - aciclovir - ointment - 3%w/w, 0.02

Estados Unidos - inglês - NLM (National Library of Medicine)

alembic pharmaceuticals inc. - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir ointment usp, 5% is indicated in the management of initial genital herpes and in limited non-life-threatening mucocutaneous herpes simplex virus infections in immunocompromised patients. acyclovir ointment 5% is contraindicated in patients who develop hypersensitivity to the components of the formulation.

Estados Unidos - inglês - NLM (National Library of Medicine)

tolmar inc. - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir 50 mg in 1 g - acyclovir ointment, 5% is indicated in the management of initial genital herpes and in limited non-life-threatening mucocutaneous herpes simplex virus infections in immunocompromised patients. acyclovir ointment, 5% is contraindicated in patients who develop hypersensitivity to the components of the formulation.

Estados Unidos - inglês - NLM (National Library of Medicine)

northstar rx llc - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir ointment usp 5% is indicated in the management of initial genital herpes and in limited non-life-threatening mucocutaneous herpes simplex virus infections in immunocompromised patients. acyclovir ointment 5% is contraindicated in patients who develop hypersensitivity to the components of the formulation.

Estados Unidos - inglês - NLM (National Library of Medicine)

torrent pharmaceuticals limited - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir ointment 5% is indicated in the management of initial genital herpes and in limited non-life-threatening mucocutaneous herpes simplex virus infections in immunocompromised patients. acyclovir ointment 5% is contraindicated in patients who develop hypersensitivity to the components of the formulation.